Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 in Healthy Japanese Infants (V114-033)
Clinical trial NCT04384107 · COMPLETED
Trial details
- NCT number
- NCT04384107
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-01
- Primary completion
- 2021-12-01
- Enrollment
- 694
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.